Aura Biosciences, Inc.
AURA
$6.55
$0.081.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 177.31M | 127.99M | 151.09M | 174.38M | 187.42M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 648.00K | 1.17M | 1.70M | 353.00K | 700.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.00M | 5.35M | 7.83M | 8.75M | 7.48M |
| Total Current Assets | 183.96M | 134.52M | 160.62M | 183.48M | 195.60M |
|
|
|||||
| Total Current Assets | 183.96M | 134.52M | 160.62M | 183.48M | 195.60M |
| Net Property, Plant & Equipment | 19.49M | 20.12M | 20.59M | 21.07M | 21.48M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 953.00K | 768.00K | 1.29M | 790.00K | 1.21M |
| Total Assets | 204.40M | 155.40M | 182.50M | 205.34M | 218.28M |
|
|
|||||
| Total Accounts Payable | 1.29M | 2.01M | 2.30M | 1.99M | 1.46M |
| Total Accrued Expenses | 10.14M | 6.57M | 8.84M | 8.54M | 5.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.20M | 3.17M | 3.15M | 3.13M | 2.75M |
| Total Finance Division Other Current Liabilities | 227.00K | 412.00K | 618.00K | 1.06M | 768.00K |
| Total Other Current Liabilities | 227.00K | 412.00K | 618.00K | 1.06M | 768.00K |
| Total Current Liabilities | 14.85M | 12.16M | 14.91M | 14.71M | 10.55M |
|
|
|||||
| Total Current Liabilities | 14.85M | 12.16M | 14.91M | 14.71M | 10.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.92M | 15.27M | 15.62M | 15.96M | 16.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 29.77M | 27.44M | 30.53M | 30.67M | 26.83M |
|
|
|||||
| Common Stock & APIC | 603.33M | 529.57M | 525.93M | 522.45M | 518.99M |
| Retained Earnings | -428.73M | -401.71M | -374.23M | -348.39M | -327.35M |
| Treasury Stock & Other | 25.00K | 105.00K | 263.00K | 607.00K | -183.00K |
| Total Common Equity | 174.63M | 127.97M | 151.97M | 174.67M | 191.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 174.63M | 127.97M | 151.97M | 174.67M | 191.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 174.63M | 127.97M | 151.97M | 174.67M | 191.45M |
|
|
|||||